Key result
The Hospital Anxiety and Depression Scale (HADS) demonstrated acceptable screening performance for major depressive disorder in breast cancer patients, with an AUC of 0.77 on the total score.
Why the study?
Does the Hospital Anxiety and Depression Scale (HADS) accurately screen for psychiatric morbidity compared to the Structured Clinical Interview for DSM-IV (SCID) in Turkish women with breast cancer?
Population
204 Turkish women with breast cancer
Comparison
Hospital Anxiety and Depression Scale (HADS) vs Structured Clinical Interview for DSM-IV (SCID)
Design
Cross-sectional
Authors
Loading...
Supports cautious HADS use for MDD screening in breast cancer; leaves open prospective validation before wider adoption.
Cross-Sectional (n=204)
Does the Hospital Anxiety and Depression Scale (HADS) accurately screen for psychiatric morbidity compared to the Structured Clinical Interview for DSM-IV (SCID) in Turkish women with breast cancer?
Effect estimate: AUC 0.77 for MDD on HADS total
HADS demonstrates acceptable sensitivity and specificity for detecting major depressive disorder in breast cancer patients and can be recommended as a screening tool with reservations.
Özalp et al. (2007) conducted a cross-sectional in Breast cancer (n=204). Hospital Anxiety and Depression Scale (HADS) vs. Structured Clinical Interview for DSM-IV (SCID) was evaluated on Screening performance for major depressive disorder (MDD) and adjustment disorders (ADs) (AUC 0.77 for MDD on HADS total). The Hospital Anxiety and Depression Scale (HADS) demonstrated acceptable screening performance for major depressive disorder in breast cancer patients, with an AUC of 0.77 on the total score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: